SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-003041
Filing Date
2020-01-07
Accepted
2020-01-07 16:19:03
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d781496d424b5.htm 424B5 516445
2 GRAPHIC g781496g44h20.jpg GRAPHIC 56805
3 GRAPHIC g781496g77r46.jpg GRAPHIC 37573
4 GRAPHIC g861846g37b74.jpg GRAPHIC 33463
  Complete submission text file 0001193125-20-003041.txt   693736
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-235830 | Film No.: 20513517
SIC: 2834 Pharmaceutical Preparations